Antibody Technology Developments (Technical Insights)


Regular Price: USD 3,950.00

Special Price USD 2,765.00

30% OFF

* Required Fields

Regular Price: USD 3,950.00

Special Price USD 2,765.00


Be the first to review this product

This research service discusses the Antibody Technology Developments across the globe.

Table of Contents

Antibody Technology Developments (Technical Insights), Executive SummaryIntroductionIntroduction to AntibodiesOverview of Antibody IndustryScope and MethodologyScope and Segmentation of the Research ServiceMethodologyAntibody Technology Developments (Technical Insights), Antibody Technology OverviewTechnology PrimerMonoclonal Versus Polyclonal AntibodiesApplicationsInnovations in Key Companies and UniversitiesEmerging Technology Innovations in CompaniesEmerging Technology Innovations in UniversitiesAntibody Technology Developments (Technical Insights), Technology Adoption Factor AnalysisTechnology AnalysisRestraintsChallengesDriversInfluential Market FactorsCorporate CollaborationsFunding SourcesAntibody Technology Developments (Technical Insights), Innovative Developments in Antibody Technologies in North AmericaCompaniesFully Human Proteins from Modified YeastNew Monoclonal Antibody Delivery and Synthesis TechnologyNovel Antibodies for Effective Antimicrobial TherapyNovel Technology Platforms for Making Monoclonal Antibodies for Cancer and Immunological DiseasesMonoclonal Antibodies for Cancer and Inflammatory DiseasesTransgenic Mice for Production of Fully Human AntibodiesAntigen Based Therapeutic Synthetic VaccinesNovel Human Antibodies against CancerUnique Antibody Based Approach for Disease Diagnosis and ManagementTherapeutic Antibodies for Inflammatory and Immunological DiseasesNovel Antibody Array to Study Cytokine Expression LevelsSimple Low Cost Assay for Studying Gene-Protein InteractionsInnovative Technology for Generation of Cancer TherapeuticsMonoclonal Antibodies for Inflammatory DiseasesAcademic InstitutionsAntibodies as a Cure for AnthraxStress Increases Antibody Production in Hybridoma Cells Grown in CultureAntibody Technology Developments (Technical Insights), Innovative Developments in Antibody Technologies in EuropeCompaniesProduction of Fully Human Antibodies through Human Combinatorial Antibody LibrariesNovel Technology Targets Bacterial HaptensAn Alternative Therapy for Malaria - Antimalarial AntibodiesAntibodies against West Nile VirusTherapeutic Monoclonal Antibodies through Phage Display LibrariesAntibody Production through Genetic Immunization TechniqueAcademic InstitutionsThe CAMPATH Series of AntibodiesAntibodies for Malarial ParasiteAntibody Technology Developments (Technical Insights), Innovative Developments in Antibody Technologies in APACCompaniesUnique Humanization Technology for Producing Antibody ProductsInnovative Technology for Producing High Affinity Monoclonal AntibodiesSmall Molecule Cytokine Antagonists as Therapy for Inflammatory DisordersImmunomodulatory Drug as a Treatment for Autoimmune and Inflammatory DisordersAcademic InstitutionsResearch for Treatment of MiscarriageStudy Shows Evidence of Link between a Common Virus and Breast CancerAntibody Technology Developments (Technical Insights), Patents and Key ContactsPatentsPatents IPatents IIKey ContactsCompaniesUniversitiesAntibody Technology Developments (Technical Insights), Frost & Sullivan 2005 Science and Technology AwardsExcellence in Technology AwardAward DescriptionAward RecipientTechnology Innovation AwardAward DescriptionAward RecipientExcellence in Research AwardAward DescriptionAward RecipientAntibody Technology Developments (Technical Insights), Critical Reference TablesDecision Support DatabasesNumber of Biotech Companies (1999 to 2006)Private Funding for Research in Biotechnology (1999 to 2006)Government Funding for Research in Biotechnology (1999 to 2006)Incidence of HIV and AIDS (1999 to 2006)Breast Cancer Incidence (1999 to 2006)Lung Cancer Incidence (1999 to 2006)Prostate Cancer Incidence (1999 to 2006)Prevalence of Alzheimer's Disease (1999 to 2006)Prevalence of Multiple Sclerosis (1999 to 2006)

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.